₹35.10
-1.50 (-4.10%)
As of 21 Sept 2026, Clinitech Laboratory Ltd share price is ₹35.10. The stock opened at ₹35.10 and had closed at ₹36.60 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹28.55 and a high of ₹47.15. In terms of performance, Clinitech Laboratory Ltd share price has increased by 1.74% over the past six months and has decreased by 20.23% over the last year.
Clinitech Lab Stock Price Chart
Clinitech Laboratory Ltd Overview
Market cap₹8 Crs
Volume1,200
Prev. Close₹36.60
Year range₹28.55 - ₹47.15
ISININE0QMR01015
About Clinitech Lab
Clinitech Laboratory is engaged in the business of providing pathology and related healthcare services.
Clinitech Laboratory Ltd Historical Performance
1 Month Return-12.25%
6 Month Return-0.28%
3 Year Return-
3 Month Return-7.14%
1 Year Return-31.67%
5 Year Return-
Clinitech Laboratory Ltd Fundamentals
ROCE(TTM)7.00%
P/E Ratio (TTM)18.97
P/B Ratio0.87
Debt to Equity0.04
ROE4.57%
EPS (TTM)1.85
Dividend Yield0.00%
Book Value40.54
Profit Margin0.00%
Operating Margin0.00%
Clinitech Laboratory Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 9.67 | 8.46 | 6.44 | 6.37 | 6.45 |
| EBITDA | 1.18 | 1.06 | 1.04 | 1.37 | 1.14 |
| Net Profit | 0.42 | 0.39 | 0.37 | 0.61 | 0.51 |
| EPS | 1.85 | 1.90 | 2.37 | 4.09 | 3.42 |
Clinitech Laboratory Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 36.60 |
| Resistance 1 (R1) | 36.60 |
| Pivot Point | 36.60 |
Clinitech Laboratory Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Jagdish Umakant Nayak | Chairman & Managing Director |
| Jyoti Jagdish Nayak | Whole-time Directorector |
| Ashutosh Jagdish Nayak | Non Executive Independent Director |
Clinitech Laboratory Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,944.50+2.01% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,049.30+1.19% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹886.00-0.01% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Clinitech Laboratory Ltd today is ₹35.10 on NSE and ₹35.10 on BSE.
- The 52-week high of Clinitech Laboratory Ltd is ₹47.15, while the 52-week low is ₹28.55.
- The current market capitalisation of Clinitech Laboratory Ltd is approximately ₹8 crore.
- The P/E (Price-to-Earnings) ratio of Clinitech Laboratory Ltd is 18.97. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Clinitech Laboratory Ltd is 0.87. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Clinitech Laboratory Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Clinitech Lab on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Clinitech Laboratory Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Clinitech Laboratory Ltd comprises different categories of shareholders. As of Mar 2026, the shareholding is approximately 64.20% promoters, 0.32% FIIs, 0.00% DIIs, and 34.17% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
